-
If approved based on review of study data, oral COVID Drug mulnupiravir may help reduce hospitalization and risk of death for specific at-risk populations.
Medical Mythbusting Commentary for October 4, 2021 Source:Oral COVID Drug Slashes Hospitalization and Death Risk, Merck Says